الفهرس 
Endovascular treatment of TASC D lesions in the femoropopliteal arterial disease : Feasibility and midterm result
AbstractOnly 14 pages are availabe for public view
 |  | from | 147 |  |  |
| | | from | 147 | | |
Abstract
The TASC II had stated clearly that TASC D femoropopliteal lesions should be surgically managed. Patients with TASC D femoropopliteal occlusive diseases have advanced cardiovascular and cerebrovascular diseases that make those patients at high risk group for surgery with significant preoperative morbidity and mortality. Advances in endovascular approaches to femoropopliteal disease have given rise to the impression that it may be better to perform a percuteanous intervention first, with the hope of a good intermediate term result, reserving and protecting the option of surgery at a later date. Our study was to evaluate the feasibility and clinical outcomes for 6 months of endovascular intervention of TASC D femoropopliteal occlusive disease. It includes 30 patients with critical limb ischemia or life style limiting claudication due to TASC D femoropopliteal atherosclerotic occlusive disease.The technical success was 90%. The secondary patency was 96.2% and 70.4% at 3 and 6 months respectively. This can gives the endovascular first approach big value as an alternative to bypass surgery in patients who are considered at high risk for surgery due to comorbidities or inadequate vein conduit.Retrograde access should be used in case in failure of antegrade recanalization Duplex surveillance is essential for all patients who underwent endovascular intervention in order to maintain the patency of the treated segment